| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,465 | 18,979 | 14,024 | 19,079 | | Cost of Revenue | 11,126 | 15,507 | 14,220 | 12,865 | | | Gross Profit | 3,339 | 3,472 | (196) | 6,214 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,692 | 5,021 | 4,918 | 5,448 | | Non Recurring |
-
| 9,705 | 145 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,353) | (11,254) | (5,259) | 766 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14) | (26) | (76) | 54 | | Earnings Before Interest And Taxes | (1,938) | (11,280) | (5,447) | 890 | | Interest Expense |
-
| 467 | 426 | 429 | | Income Before Tax | (1,938) | (11,747) | (5,873) | 461 | | Income Tax Expense | (120) | (2,725) | (859) | 129 | | Minority Interest |
-
|
-
| (112) | 70 | | | | Net Income From Continuing Ops | (1,818) | (9,022) | (5,014) | 332 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,818) | (9,022) | (5,014) | 332 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,818) | ($9,022) | ($5,014) | $332 |
|
0.51% Nasdaq 
Income Statement
